Acurx Pharmaceuticals LLC
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,307 | -1,680 | -1,578 | -1,992 |
EBIT | 6,411 | |||
Net Income | -2,254 | -1,680 | -1,578 | -1,992 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,709 | -1,407 | -1,184 | -1,880 |
Cash | 10,656 | 9,254 | 7,556 | 5,906 |
Basic Shares | 4,259 | 1,499 | 1,499 | 1,625 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -7,966 | -14,103 | -14,577 | -12,092 |
EBIT | -14,103 | -29,156 | -24,186 | |
Net Income | -7,966 | -14,103 | -14,577 | -12,092 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,787 | -10,383 | -9,800 | -7,542 |
Cash | 7,556 | 3,706 | 7,474 | 9,111 |
Basic Shares | 1,499 | 851 | 633 | 540 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.53 |
2026-03-31 | -$0.62 |
2025-12-31 | -$0.31 |
2025-09-30 | -$1.23 |